CHTR vs TIGO vs ASTS
161 measures in 16 categories, one definition each, computed from filings and market data.
CHTR38.4
Charter Communications, Inc.
Communication Services · Telecommunications Services
$110.11 +0.11%$14.8B mkt cap
Score DNA
TIGO42.5
Millicom International Cellular S.A.
Communication Services · Telecommunications Services
$82.86 +0.97%$13.9B mkt cap
Score DNA
ASTS35.9
AST SpaceMobile, Inc.
Communication Services · Telecommunications Services
$40.66 −8.55%$16.6B mkt cap
Score DNA
Price, rebased to 100 three years ago
CHTR TIGO ASTS · weekly adjusted closesSmart money 8Valuation 16Profitability (TTM) 12Returns on capital 11Growth 17Margin history & stability 7Liquidity (latest quarter) 7Leverage & solvency (latest quarter) 13Efficiency 11Cash flow & earnings quality 7Dividends & buybacks 9Scores & forensic checks 15Per share 7Size (TTM) 8Price performance 9Technicals 4
● marks the highest or lowest value where that direction is plainly stronger (margins, returns, coverage, leverage); multiples and yields are left unmarked. Bars show each stock's percentile within its own industry. n/a: the measure does not apply to lenders and insurers.
Smart money
8 measures| Measure | CHTR | TIGO | ASTS |
|---|---|---|---|
| Insider open-market buys, 180d | 5 | 0 | 3 |
| Insider $ bought, 180d | $3.76M | — | $0.62M |
| Congress purchases, 180d | 1 | 0 | 0 |
| Last Congress purchase | 2026-08-10 | — | — |
| 13F net change in holders | −3 | +68 | +68 |
| ETFs adding shares, 30d | 853 | 464 | 556 |
| ETFs trimming, 30d | 744 | 318 | 381 |
| Net ETF funds, 30d | +109 | +146 | +175 |
Valuation
16 measures| Measure | CHTR | TIGO | ASTS |
|---|---|---|---|
| P/E (TTM) | 3.0x
13th
|
20.9x
78th
|
— |
| PEG (P/E ÷ 3-yr EPS CAGR) | 0.30
57th
|
0.06
29th
|
— |
| Price / sales | 0.3x
3rd
|
1.9x
64th
|
144.0x
97th
|
| Price / book | 0.9x
32nd
|
5.5x
84th
|
8.8x
94th
|
| Price / tangible book | — | — | 16.7x
86th
|
| Price / free cash flow | 3.4x
4th
|
9.0x
46th
|
— |
| Price / operating cash flow | 0.9x
7th
|
6.0x
68th
|
— |
| Enterprise value | $111.0B
85th
|
$24.9B
76th
|
$17.3B
73rd
|
| EV / sales | 2.0x
27th
|
3.4x
73rd
|
150.1x
97th
|
| EV / EBITDA | 5.4x
38th
|
7.5x
59th
|
— |
| EV / EBIT | 8.7x
31st
|
15.0x
65th
|
— |
| EV / free cash flow | 25.5x
75th
|
16.2x
33rd
|
— |
| Earnings yield | 33.2%
91st
|
4.8%
45th
|
-3.7%
24th
|
| FCF yield | 29.4%
97th
|
11.1%
67th
|
-9.9%
6th
|
| Operating cash flow yield | 111.0%
94th
|
16.8%
42nd
|
-0.9%
12th
|
| Graham number (per share) | $357.40
100th
|
$36.64
48th
|
— |
Profitability (TTM)
12 measures| Measure | CHTR | TIGO | ASTS |
|---|---|---|---|
| Gross margin | 46.0%
36th
|
62.9%
79th
|
-14.0%
0th
|
| EBITDA margin | 37.7%
71st
|
46.1%
89th
|
-588.7%
0th
|
| Operating margin | 23.9%
86th
|
24.0%
93rd
|
-519.5%
0th
|
| EBIT margin | 23.5%
82nd
|
23.0%
75th
|
-646.3%
0th
|
| Net margin | 9.1%
61st
|
9.2%
64th
|
-536.7%
0th
|
| NOPAT margin | 18.3%
93rd
|
16.2%
71st
|
-410.4%
0th
|
| FCF margin | 8.0%
47th
|
21.3%
94th
|
-1,420.7%
0th
|
| Operating cash flow margin | 30.3%
65th
|
32.1%
84th
|
-125.5%
13th
|
| R&D / revenue | 0.0%
0th
|
0.0%
0th
|
61.0%
97th
|
| SG&A / revenue | 17.1%
21st
|
30.4%
70th
|
141.9%
97th
|
| Stock comp / revenue | 1.2%
64th
|
0.0%
0th
|
128.3%
97th
|
| Effective tax rate | 23.6%
74th
|
32.7%
97th
|
21.0%
35th
|
Returns on capital
11 measures| Measure | CHTR | TIGO | ASTS |
|---|---|---|---|
| ROE (on average equity) | 29.7%
91st
|
21.9%
69th
|
-44.8%
3rd
|
| ROA | 3.2%
39th
|
3.7%
45th
|
-16.0%
0th
|
| ROIC | 8.8%
73rd
|
8.6%
64th
|
-18.2%
3rd
|
| ROCE | 9.0%
61st
|
10.7%
67th
|
-13.2%
9th
|
| Return on tangible assets | 8.3%
64th
|
9.3%
73rd
|
-19.3%
0th
|
| Cash ROIC (OCF / invested capital) | 14.6%
59th
|
17.1%
72nd
|
-5.6%
12th
|
| Gross profitability (GP / assets) | 15.0%
48th
|
22.0%
64th
|
-0.3%
0th
|
| ROIC, 3-yr average | 5.3%
54th
|
5.1%
46th
|
— |
| ROIC, 5-yr average | 5.7%
74th
|
5.3%
70th
|
6.0%
78th
|
| ROE, 5-yr average | 39.5%
100th
|
15.0%
71st
|
-44.7%
7th
|
| Incremental ROIC | 504.8%
100th
|
17.8%
67th
|
-5.5%
50th
|
Growth
17 measures| Measure | CHTR | TIGO | ASTS |
|---|---|---|---|
| Revenue growth (TTM YoY) | -1.5%
23rd
|
29.1%
93rd
|
2,256.9%
100th
|
| Revenue growth (QoQ) | -0.5%
36th
|
9.8%
94th
|
113.9%
100th
|
| Revenue CAGR, 3 yr | -0.1%
40th
|
9.4%
77th
|
202.4%
100th
|
| Revenue CAGR, 5 yr | 1.7%
53rd
|
12.0%
83rd
|
68.4%
100th
|
| Gross profit CAGR, 3 yr | -2.6%
38th
|
14.2%
83rd
|
— |
| Operating income CAGR, 3 yr | 1.5%
38th
|
30.4%
67th
|
— |
| Net income growth (TTM YoY) | -6.5%
58th
|
-30.1%
25th
|
— |
| Net income CAGR, 3 yr | 2.1%
22nd
|
356.3%
89th
|
— |
| EPS growth (TTM YoY) | 9.3%
54th
|
-30.3%
23rd
|
— |
| EPS CAGR, 3 yr | 10.1%
22nd
|
359.2%
100th
|
— |
| EPS CAGR, 5 yr | 15.8%
45th
|
— | — |
| FCF growth (TTM YoY) | 1.3%
30th
|
39.6%
75th
|
— |
| FCF CAGR, 3 yr | 3.1%
39th
|
64.5%
94th
|
— |
| Operating cash flow CAGR, 3 yr | 5.1%
46th
|
23.6%
83rd
|
— |
| Book value CAGR, 3 yr | 26.6%
93rd
|
-10.7%
36th
|
48.5%
100th
|
| Dividend CAGR, 3 yr | — | — | — |
| Sustainable growth rate | 29.7%
96th
|
-4.2%
17th
|
— |
Margin history & stability
7 measures| Measure | CHTR | TIGO | ASTS |
|---|---|---|---|
| Gross margin, 3-yr average | 44.8%
17th
|
60.2%
63rd
|
-123.4%
0th
|
| Operating margin, 3-yr average | 23.9%
82nd
|
22.0%
75th
|
— |
| Net margin, 3-yr average | 9.0%
46th
|
9.3%
50th
|
— |
| FCF margin, 3-yr average | 7.5%
45th
|
17.8%
83rd
|
— |
| Revenue stability (0-1) | 0.65
53rd
|
0.85
60th
|
0.37
13th
|
| Earnings stability (0-1) | 0.18
30th
|
0.36
70th
|
0.80
93rd
|
| Margin stability (0-1) | 0.90
73rd
|
0.84
37th
|
0.00
0th
|
Liquidity (latest quarter)
7 measures| Measure | CHTR | TIGO | ASTS |
|---|---|---|---|
| Cash & short-term investments | $509.0M
52nd
|
$861.0M
61st
|
$2.3B
73rd
|
| Net cash (− = net debt) | −$96.2B
12th
|
−$11.0B
27th
|
−$705.5M
73rd
|
| Working capital | −$8.8B
3rd
|
−$2.4B
12th
|
$2.3B
97th
|
| Current ratio | 0.36
0th
|
0.53
3rd
|
13.05
100th
|
| Quick ratio | 0.36
0th
|
0.51
3rd
|
12.90
100th
|
| Cash ratio (cash + ST investments / current liabilities) | 0.04
3rd
|
0.17
12th
|
11.98
100th
|
| Defensive interval (days) | 146 days
22nd
|
201 days
37th
|
1,483 days
96th
|
Leverage & solvency (latest quarter)
13 measures| Measure | CHTR | TIGO | ASTS |
|---|---|---|---|
| Total debt | $96.7B
88th
|
$11.9B
73rd
|
$3.0B
52nd
|
| Debt / equity | 5.70
94th
|
4.70
90th
|
1.58
74th
|
| Net debt / equity | 5.67
94th
|
4.36
90th
|
0.37
19th
|
| Debt / assets | 62.1%
88th
|
57.6%
85th
|
51.1%
76th
|
| Debt / capital | 85.1%
94th
|
82.5%
90th
|
61.3%
74th
|
| Debt / EBITDA | 4.71
79th
|
3.57
59th
|
— |
| Net debt / EBITDA | 4.69
83rd
|
3.31
69th
|
— |
| Interest coverage (EBIT / interest) | 2.5x
42nd
|
1.8x
35th
|
−12.3x
0th
|
| Cash interest coverage | 3.2x
55th
|
2.6x
26th
|
−2.4x
13th
|
| Debt payback (years of OCF) | 5.9 yrs
68th
|
5.1 yrs
57th
|
— |
| Liabilities / assets | 85.9%
82nd
|
87.9%
85th
|
59.0%
36th
|
| IS credit model rating | B- | B- | BBB+ |
| Implied credit spread (bps) | 900
82nd
|
900
82nd
|
225
21st
|
Efficiency
11 measures| Measure | CHTR | TIGO | ASTS |
|---|---|---|---|
| Asset turnover | 0.35
55th
|
0.41
70th
|
0.03
3rd
|
| Fixed asset turnover | 1.13
58th
|
1.55
76th
|
0.06
0th
|
| Inventory turnover | — | 30.7
79th
|
9.3
47th
|
| Receivables turnover | 15.1
88th
|
13.7
79th
|
2.9
18th
|
| Days sales outstanding | 24 days
12th
|
27 days
21st
|
126 days
82nd
|
| Days inventory outstanding | — | 12 days
21st
|
39 days
53rd
|
| Days payables outstanding | 12 days
3rd
|
78 days
41st
|
116 days
66th
|
| Cash conversion cycle (days) | 12 days
66th
|
−40 days
34th
|
49 days
78th
|
| Capex / revenue | 22.3%
71st
|
10.8%
21st
|
1,295.2%
100th
|
| Capex / depreciation | 1.56
86th
|
0.47
4th
|
22.49
100th
|
| Operating expense ratio | 21.9%
4th
|
29.0%
19th
|
969.3%
100th
|
Cash flow & earnings quality
7 measures| Measure | CHTR | TIGO | ASTS |
|---|---|---|---|
| Operating cash flow / net income | 3.34
70th
|
3.50
78th
|
— |
| FCF / net income | 0.89
57th
|
2.32
87th
|
— |
| FCF / operating cash flow | 26.5%
30th
|
66.3%
85th
|
— |
| Capex / operating cash flow | 73.5%
70th
|
33.7%
15th
|
— |
| Accruals ratio | -7.5%
55th
|
-9.3%
33rd
|
-12.3%
24th
|
| Sloan accruals ratio | -4.4%
64th
|
-20.9%
6th
|
35.7%
97th
|
| Earnings quality score (0-1) | 0.75
35th
|
0.75
35th
|
— |
Scores & forensic checks
15 measures| Measure | CHTR | TIGO | ASTS |
|---|---|---|---|
| IS score | 38
55th
|
42
64th
|
36
39th
|
| IS profitability | 59
61st
|
54
55th
|
8
0th
|
| IS growth | 35
20th
|
43
47th
|
52
50th
|
| IS value | 80
76th
|
49
45th
|
27
3rd
|
| IS momentum | 65
63rd
|
70
77th
|
50
23rd
|
| IS risk (safety) | 15
3rd
|
15
3rd
|
100
88th
|
| IS quality | 56
52nd
|
50
42nd
|
35
9th
|
| IS balance sheet | 11
0th
|
21
15th
|
31
24th
|
| IS earnings quality | 78
91st
|
72
73rd
|
33
21st
|
| IS cash flow | 46
48th
|
72
97th
|
30
30th
|
| Piotroski F-score (0-9) | 6
64th
|
4
3rd
|
4
3rd
|
| Altman Z-score | 0.6
30th
|
1.1
52nd
|
4.4
91st
|
| Beneish M-score | −2.79
67th
|
−2.18
87th
|
23.37
100th
|
| Ohlson O-score | −6.62
73rd
|
−5.59
88th
|
−6.71
70th
|
| IS credit score | 24
12th
|
25
18th
|
61
79th
|
Size (TTM)
8 measures| Measure | CHTR | TIGO | ASTS |
|---|---|---|---|
| Market cap | $14.8B
79th
|
$13.9B
76th
|
$16.6B
85th
|
| Revenue | $54.4B
82nd
|
$7.2B
73rd
|
$115.3M
3rd
|
| EBITDA | $20.5B
82nd
|
$3.3B
76th
|
−$678.8M
9th
|
| Net income | $4.9B
79th
|
$665.0M
64th
|
−$618.8M
12th
|
| Free cash flow | $4.4B
82nd
|
$1.5B
79th
|
−$1.6B
0th
|
| Total assets | $155.6B
82nd
|
$20.7B
64th
|
$5.9B
48th
|
| Shareholders' equity | $17.0B
82nd
|
$2.5B
64th
|
$1.9B
61st
|
| Employees | 91,900
91st
|
14,250
73rd
|
1,126
18th
|
Price performance
9 measures| Measure | CHTR | TIGO | ASTS |
|---|---|---|---|
| 1 day | +0.1% | +1.0% | −8.6% |
| 1 week | +6.5% | +4.3% | −20.2% |
| 1 month | −17.4% | −13.4% | −35.2% |
| 3 months | −14.8% | −14.9% | −29.2% |
| 6 months | −53.5% | +1.8% | −52.5% |
| Year to date | −47.4% | +48.7% | −51.3% |
| 1 year | −58.4% | +77.2% | −57.5% |
| 3 years, cumulative | −75.5% | +495.3% | +1,082.0% |
| 5 years, cumulative | −84.4% | +168.2% | +304.2% |
Technicals
4 measures| Measure | CHTR | TIGO | ASTS |
|---|---|---|---|
| RSI 14 | 40.9 | 40.0 | 29.1 |
| From 52-week high | −58.6% | −22.6% | −69.6% |
| From 52-week low | +8.3% | +84.7% | +2.0% |
| Beta | 0.69 | 0.90 | 2.71 |
InsiderStreet reports findings from filings and market data. A comparison is not a recommendation to buy or sell either stock.Every figure is computed in code · data as of 2026-10-17